Actively Recruiting
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
Led by Centro Cardiopatici Toscani · Updated on 2019-09-12
2500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
Sponsors
C
Centro Cardiopatici Toscani
Lead Sponsor
A
Azienda USL 4 Prato
Collaborating Sponsor
AI-Summary
What this Trial Is About
Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.
CONDITIONS
Official Title
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of acute coronary syndrome (ST elevation or non-ST elevation)
- Scheduled for early invasive strategy
You will not qualify if you...
- Contraindication to statin therapy
- Refusal to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cardiology Division, Prato Hospital
Prato, Italy, 59100
Actively Recruiting
Research Team
A
Anna Toso, MD
CONTACT
M
Mario Leoncini, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here